Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

US Patent 11254725 · Granted Feb 22, 2022

Estimated economic value: $87,970,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes an2025
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of 2022
Lysosomal targeting peptides and uses thereof2022
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes an2021
Variants of C-type natriuretic peptide2020
Variants of C-type natriuretic peptide2020
Variants of C-type natriuretic peptide2020
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2020
Targeted therapeutic proteins2019